BDH Industries Reports Strong Q2 FY2026 Results with 17% Revenue Growth
BDH Industries Limited announced financial results for Q2 and H1 FY2026 ended September 30, 2025. Q2 revenue increased 16.80% to ₹1,895.92 lakhs, with profit after tax up 8.81% to ₹261.91 lakhs. H1 revenue grew 15.68% to ₹3,758.34 lakhs, while profit after tax rose 11.83% to ₹444.57 lakhs. The Pharmaceuticals segment contributed ₹1,875.27 lakhs to quarterly revenue, with Renewable Energy adding ₹20.65 lakhs. Cash and cash equivalents stood at ₹3,612.50 lakhs as of September 30, 2025.

*this image is generated using AI for illustrative purposes only.
BDH Industries Limited has announced its financial results for the second quarter and half-year ended September 30, 2025, showcasing robust growth across key financial metrics. The company, which operates in the Pharmaceuticals and Renewable Energy sectors, has demonstrated resilience and continued expansion in its business operations.
Financial Highlights
The company's performance for Q2 FY2026 and H1 FY2026 is summarized in the table below:
| Particulars (₹ in lakhs) | Q2 FY2026 | Q2 FY2025 | YoY Growth | H1 FY2026 | H1 FY2025 | YoY Growth |
|---|---|---|---|---|---|---|
| Revenue from Operations | 1895.92 | 1623.22 | 16.80% | 3758.34 | 3249.04 | 15.68% |
| Profit After Tax | 261.91 | 240.71 | 8.81% | 444.57 | 397.56 | 11.83% |
BDH Industries has reported a significant year-on-year growth of 16.80% in its revenue from operations for Q2 FY2026, reaching ₹1,895.92 lakhs compared to ₹1,623.22 lakhs in the same quarter of the previous year. The company's profit after tax also saw an increase, rising to ₹261.91 lakhs from ₹240.71 lakhs, marking an 8.81% growth.
For the half-year period, the company's revenue stood at ₹3,758.34 lakhs, up by 15.68% from ₹3,249.04 lakhs in the previous year. The profit after tax for H1 FY2026 increased by 11.83% to ₹444.57 lakhs from ₹397.56 lakhs in H1 FY2025.
Segment-wise Performance
BDH Industries operates in two business segments:
- Pharmaceuticals: This segment contributed ₹1,875.27 lakhs to the quarterly revenue.
- Renewable Energy: This segment added ₹20.65 lakhs to the quarterly revenue.
The pharmaceutical segment continues to be the primary revenue driver for the company, reflecting its strong position in the healthcare sector.
Financial Position
As of September 30, 2025, BDH Industries reported cash and cash equivalents of ₹3,612.50 lakhs, indicating a strong liquidity position. This robust cash reserve provides the company with financial flexibility for potential investments and growth opportunities.
Corporate Governance
The Board of Directors of BDH Industries Limited approved these unaudited financial results at their meeting held on November 12, 2025. The meeting commenced at 4:00 p.m. and concluded at 6:30 p.m., as disclosed in the company's filing.
In compliance with SEBI regulations, the company has stated that these financial results will be published in newspapers as per the prescribed format. Additionally, M/s. CLB & Associates, Chartered Accountants, the statutory auditors, have conducted a limited review of the financial results.
BDH Industries' strong performance in Q2 and H1 FY2026 demonstrates its ability to grow revenue and maintain profitability in a competitive market environment. The company's diverse operations in pharmaceuticals and renewable energy, coupled with its solid financial position, suggest a positive outlook for the remainder of the fiscal year.
Historical Stock Returns for BDH Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.86% | -3.69% | -9.56% | +48.04% | +1.86% | +353.46% |





























